DFTX peer analysis
Definium Therapeutics (DFTX) against its competitors: price, today's move, 1-year return and market value side by side.
DFTX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ANRO Alto Neuroscience | $25.03 | 14.45% | 121.70% | – |
| ATHE Alterity Therapeutics | $2.22 | -9.02% | -43.08% | $42.39M |
| AXSM Axsome Therapeutics | $132.37 | 1.98% | -2.45% | $6.93B |
| GHRS GH Research | $18.61 | 0.92% | 36.94% | – |
| LBRX LB Pharmaceuticals | $42.50 | 11.58% | 162.35% | – |
| MPLT MapLight Therapeutics | $7.60 | 22.19% | -52.50% | – |
| NERV Minerva Neurosciences | $2.30 | -10.51% | -39.79% | $109.82M |
| NMRA Neumora Therapeutics | $0.49 | -13.96% | -81.41% | – |
| PRAX Praxis Precision Medicines | $279.00 | 6.25% | 69.46% | – |
| RAPP Rapport Therapeutics | $24.44 | 3.04% | -6.61% | – |
| DFTX Definium Therapeutics | $33.42 | 10.08% | – | – |
- DFTX's peers: ANRO (Alto Neuroscience), ATHE (Alterity Therapeutics), AXSM (Axsome Therapeutics), GHRS (GH Research), LBRX (LB Pharmaceuticals), MPLT (MapLight Therapeutics), NERV (Minerva Neurosciences), NMRA (Neumora Therapeutics).
Updated 2026-11-07 11:53 UTC